Alphamab Oncology (HKG:9966)
8.97
+0.07 (0.79%)
Feb 13, 2026, 4:08 PM HKT
124.25% (1Y)
| Market Cap | 8.69B +166.3% |
| Revenue (ttm) | 861.24M +207.2% |
| Net Income | 255.11M |
| EPS | 0.26 |
| Shares Out | 968.57M |
| PE Ratio | 34.65 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,132,000 |
| Average Volume | 1,479,320 |
| Open | 9.30 |
| Previous Close | 8.90 |
| Day's Range | 8.80 - 9.30 |
| 52-Week Range | 3.73 - 15.75 |
| Beta | 0.40 |
| RSI | 43.42 |
| Earnings Date | Mar 27, 2026 |